<DOC>
	<DOCNO>NCT02522468</DOCNO>
	<brief_summary>The purpose randomize trial determine superiority utilize radioactive seed localization ( RSL ) wire-guided localization ( WL ) palpable non-palpable malignant lesion patient undergo breast conservation surgery ( BCS ) .</brief_summary>
	<brief_title>A Trial RSL Versus WL Malignant Breast Disease</brief_title>
	<detailed_description>Consented eligible subject randomize either radioactive seed localization wire localization stratify surgeon invasive versus DCIS prior localization . Subjects arm undergo breast conservation surgery include surgical specimen removal . Specimens gross accord standard care procedure . Localization , breast conservation surgery , post-operative appointment follow standard care guideline . Surveys administer accord study calendar radiologist , surgeon , pathologist , subject data collection .</detailed_description>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>Female 20 85 year age Breast lesion necessitate imageguided excision Unifocal disease Breastconservation candidate Biopsyproven malignant breast lesion include limited invasive ductal carcinoma , invasive lobular carcinoma , ductal carcinoma situ Signed write informed consent document subject and/or LAR Male Multifocal multicentric disease Receiving neoadjuvant chemotherapy Pregnant breastfeeding Locally advance disease Breast conservation contraindication inability receive whole breast radiation therapy , inability tolerate localization procedure , inability lay flat prone radiation , undesirable tumor breast ratio Prior breast cancer ipsilateral side Unable unwilling adhere postlocalization instruction ( e.g . timely seed removal )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>